278 related articles for article (PubMed ID: 36233356)
61. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
62. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
Kochiashvili G; Kochiashvili D
Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
[TBL] [Abstract][Full Text] [Related]
63. Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model.
Li J; Luo H; Dong X; Liu Q; Wu C; Zhang T; Hu X; Zhang Y; Song B; Li L
Stem Cell Res Ther; 2017 May; 8(1):107. PubMed ID: 28482861
[TBL] [Abstract][Full Text] [Related]
64. EBV infection mediated BDNF expression is associated with bladder inflammation in interstitial cystitis/bladder pain syndrome with Hunner's lesion.
Jhang JF; Liu CD; Hsu YH; Chen CC; Chen HC; Jiang YH; Wu WC; Peng CW; Kuo HC
J Pathol; 2023 Mar; 259(3):276-290. PubMed ID: 36441149
[TBL] [Abstract][Full Text] [Related]
65. APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis.
Zhang CO; Li ZL; Kong CZ
BMC Urol; 2005 Apr; 5():7. PubMed ID: 15862132
[TBL] [Abstract][Full Text] [Related]
66. Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome.
Abid MSR; Qiu H; Tripp BA; de Lima Leite A; Roth HE; Adamec J; Powers R; Checco JW
Sci Rep; 2022 May; 12(1):8289. PubMed ID: 35585122
[TBL] [Abstract][Full Text] [Related]
67. Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity.
Mazeaud C; Rigaud J; Levesque A; Madec FX; Le Clerc QC; Wack M; Le Normand L; Riant T; Perrouin-Verbe MA
Urology; 2019 Jan; 123():87-92. PubMed ID: 30170094
[TBL] [Abstract][Full Text] [Related]
68. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome.
Kuo YC; Kuo HC
Int J Clin Pract; 2013 Sep; 67(9):863-9. PubMed ID: 23952465
[TBL] [Abstract][Full Text] [Related]
69. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
70. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
Peng CH; Jhang JF; Shie JH; Kuo HC
Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
[TBL] [Abstract][Full Text] [Related]
71. Integrated mRNA-miRNA transcriptome analysis of bladder biopsies from patients with bladder pain syndrome identifies signaling alterations contributing to the disease pathogenesis.
Gheinani AH; Akshay A; Besic M; Kuhn A; Keller I; Bruggmann R; Rehrauer H; Adam RM; Burkhard FC; Monastyrskaya K
BMC Urol; 2021 Dec; 21(1):172. PubMed ID: 34876093
[TBL] [Abstract][Full Text] [Related]
72. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
73. Update on Urinary Tract Markers in Interstitial Cystitis/Bladder Pain Syndrome.
Grigorescu B; Powers K; Lazarou G
Female Pelvic Med Reconstr Surg; 2016; 22(1):16-23. PubMed ID: 26571430
[TBL] [Abstract][Full Text] [Related]
74. The Role of Immunoglobulin E in the Pathogenesis of Ketamine Related Cystitis and Ulcerative Interstitial Cystitis: An Immunohistochemical Study.
Jhang JF; Hsu YH; Jiang YH; Kuo HC
Pain Physician; 2016 May; 19(4):E581-7. PubMed ID: 27228524
[TBL] [Abstract][Full Text] [Related]
75. [Hydrodistention of the bladder in patients with interstitial cystitis--clinical efficacy and its association with immunohistochemical findings for bladder tissues].
Inoue R; Takahashi S; Sunaoshi K; Ichihara K; Masumori N; Tsukamoto T
Hinyokika Kiyo; 2006 Oct; 52(10):765-8. PubMed ID: 17131863
[TBL] [Abstract][Full Text] [Related]
76. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
77. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
78. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment.
Yeh HL; Jhang JF; Kuo YC; Kuo HC
Neurourol Urodyn; 2019 Sep; 38(7):1985-1993. PubMed ID: 31310370
[TBL] [Abstract][Full Text] [Related]
79. Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder?
Peters KM; Diokno AC; Steinert BW
Urology; 1999 Sep; 54(3):450-3. PubMed ID: 10475352
[TBL] [Abstract][Full Text] [Related]
80. Early and recent exposure to adversity, TLR-4 stimulated inflammation, and diurnal cortisol in women with interstitial cystitis/bladder pain syndrome: A MAPP research network study.
Lutgendorf SK; Zia S; Luo Y; O'Donnell M; van Bokhoven A; Bradley CS; Gallup R; Pierce J; Taple BJ; Naliboff BD; Quentin Clemens J; Kreder KJ; Schrepf A
Brain Behav Immun; 2023 Jul; 111():116-123. PubMed ID: 37001828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
